Low-grade cutaneous immune-related adverse events leading to immunotherapy discontinuation

被引：1
|
作者：
Jacoby, Ted V. [1 ,2 ]
Asdourian, Maria S. [2 ,3 ]
Shah, Nishi [2 ,4 ]
Otto, Tracey S. [2 ,5 ]
Thompson, Leah L. [2 ,3 ]
Reynolds, Kerry L. [6 ]
Chen, Steven T. [2 ,3 ]
机构：
[1] Univ Hawaii Manoa, John A Burns Sch Med, Honolulu, HI USA
[2] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA
[3] Harvard Med Sch, Boston, MA 02114 USA
[4] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA
[5] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA
[6] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA USA
来源：
CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2023年 / 48卷 / 09期
关键词：
D O I：
10.1093/ced/llad180
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1058 / 1060
页数：3
相关论文
共 50 条
  • [11] Management of immune-related cutaneous adverse events with dupilumab
    Kuo, Alyce Mei-Shiuan
    Gu, Stephanie
    Stoll, Joseph
    Moy, Andrea P.
    Dusza, Stephen W.
    Gordon, Allison
    Haliasos, Elena C.
    Janjigian, Yelena
    Kraehenbuehl, Lukas
    Quigley, Elizabeth A.
    Chapman, Paul
    Lacouture, Mario E.
    Markova, Alina
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (06)
  • [12] Treatment Outcomes of Immune-Related Cutaneous Adverse Events
    Phillips, Gregory S.
    Wu, Jennifer
    Hellmann, Matthew D.
    Postow, Michael A.
    Rizvi, Naiyer A.
    Freites-Martinez, Azael
    Chan, Donald
    Dusza, Stephen
    Motzer, Robert J.
    Rosenberg, Jonathan E.
    Callahan, Margaret K.
    Chapman, Paul B.
    Geskin, Larisa
    Lopez, Adriana T.
    Reed, Vanessa A.
    Fabbrocini, Gabriella
    Annunziata, Maria Carmela
    Kukoyi, Oluwaseun
    Pabani, Aliyah
    Yang, Chih-Hsun
    Chung, Wen-Hung
    Markova, Alina
    Lacouture, Mario E.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (30) : 2746 - +
  • [13] Rapid Unmasking of Immune-related Adverse Events After Discontinuation of Chemotherapy in Chemo-immunotherapy Regimens
    Riopel, Nicholas D.
    Chu, Quincy
    Walker, John
    Ye, Carrie
    JOURNAL OF IMMUNOTHERAPY, 2022, 45 (04) : 207 - 209
  • [14] Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events
    Middha, Pooja
    Thummalapalli, Rohit
    Quandt, Zoe
    Balaratnam, Karmugi
    Cardenas, Eduardo
    Falcon, Christina J.
    Margaret Lung Group, Princess
    Gubens, Matthew A.
    Huntsman, Scott
    Khan, Khaleeq
    Li, Min
    Lovly, Christine M.
    Patel, Devalben
    Zhan, Luna Jia
    Liu, Geoffrey
    Aldrich, Melinda C.
    Schoenfeld, Adam
    Ziv, Elad
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (03)
  • [15] Immune-related adverse events and the balancing act of immunotherapy COMMENT
    Conroy, Michael
    Naidoo, Jarushka
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [16] Predictors of immunotherapy-induced immune-related adverse events
    Kartolo, A.
    Sattar, J.
    Sahai, V
    Baetz, T.
    Lakoff, J. M.
    CURRENT ONCOLOGY, 2018, 25 (05) : E403 - E410
  • [17] Immunotherapy in combination with neoadjuvant therapy and immune-related adverse events
    Smyth, Mark J.
    Liu, Jing
    Blake, Stephen J.
    Teng, Michele W. L.
    CANCER RESEARCH, 2016, 76
  • [18] Rheumatic immune-related adverse events from cancer immunotherapy
    Leonard H. Calabrese
    Cassandra Calabrese
    Laura C. Cappelli
    Nature Reviews Rheumatology, 2018, 14 : 569 - 579
  • [19] UPDATES IN ENDOCRINE IMMUNE-RELATED ADVERSE EVENTS IN ONCOLOGY IMMUNOTHERAPY
    Coniac, S.
    Stoian, M.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2021, 17 (02) : 286 - 289
  • [20] Circulating biomarkers of response to immunotherapy and immune-related adverse events
    Garrison, Zachary
    Hornick, Noah
    Cheng, Jeffrey
    Kulkarni, Rajan P.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2022, 22 (09) : 855 - 865
12345